Arrowhead Pharmaceuticals, Inc.
MX ˙ BMV ˙ US04280A1007
SecurityMX:ARWR / Arrowhead Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in ARWR / Arrowhead Pharmaceuticals, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Arrowhead Pharmaceuticals, Inc. (MX:ARWR) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 2,651 shares of Arrowhead Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ARWR) in the form of stock options. The firm currently holds call options representing 71,400 of underlying shares valued at $4,740,246 USD and put options representing 2,000 of underlying shares valued at $132,780 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:ARWR / Arrowhead Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -2,651 -100.00 0 -100.00
2025-11-12 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 2,651 -16,703 -86.30 91 -70.16 0.0002
2025-08-14 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 19,354 19,354 306 0.0007
2025-05-14 2024-12-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -2,976 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -2,976 0
2024-11-14 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 2,976 2,390 407.85 58 280.00 0.0002
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 586 586 15 0.0001
2024-05-10 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -5,960 -100.00 0 -100.00
2024-02-14 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 5,960 1,949 48.59 182 70.09 0.0005
2023-11-09 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 4,011 -9,690 -70.72 108 -78.07 0.0004
2023-08-09 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 13,701 6,043 78.91 489 151.55 0.0016
2023-05-12 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 7,658 -30,100 -79.72 195 -87.33 0.0007
2023-02-09 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 37,758 15,449 69.25 1,531 107.73 0.0036
2022-11-09 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 22,309 4,834 27.66 737 19.84 0.0014
2022-08-11 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 17,475 -1,862 -9.63 615 -30.82 0.0010
2022-05-12 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 19,337 -57,443 -74.82 889 -82.54 0.0009
2022-02-11 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 76,780 400 0.52 5,091 6.77 0.0041
2021-11-12 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 76,380 11,355 17.46 4,768 -11.46 0.0051
2021-08-10 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 65,025 -2,341 -3.48 5,385 20.55 0.0065
2021-05-12 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 67,366 30,416 82.32 4,467 57.57 0.0066
2021-02-10 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 36,950 -37,154 -50.14 2,835 -11.16 0.0049
2020-11-12 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 74,104 50,033 207.86 3,191 206.83 0.0100
2020-08-13 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 24,071 -62,278 -72.12 1,040 -58.13 0.0048
2020-05-13 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 86,349 62,627 264.00 2,484 65.05 0.0201
2020-02-10 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 23,722 4,707 24.75 1,505 180.78 0.0102
2019-11-12 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 19,015 19,015 536 0.0043
2019-08-09 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -25,007 -100.00 0 -100.00
2019-05-14 2019-03-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 25,007 -12,909 -34.05 459 -2.55 0.0051
2019-05-13 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 25,007 -12,909 459
2019-02-05 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 37,916 37,916 471 0.0041
2018-11-08 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -7,793 -100.00 0 -100.00
2018-08-13 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 7,793 -60,945 -88.66 106 -78.63 0.0009
2018-05-16 2018-03-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 68,738 68,738 496 0.0050
2018-05-10 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 68,738 68,738 496
2017-11-14 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -105,588 -100.00 0 -100.00
2017-08-14 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 105,588 -5,300 -4.78 171 -16.59 0.0018
2017-05-10 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 110,888 -30,972 -21.83 205 -6.82 0.0024
2017-02-15 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 141,860 82,028 137.10 220 -50.00 0.0021
2016-11-14 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 59,832 58,169 3,497.84 440 4,788.89 0.0048
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 1,663 1,663 9 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 71,400 77.61 4,740 241.99 n/a n/a n/a
2025-11-12 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 40,200 -4.06 1,386 109.37 n/a n/a n/a
2025-08-14 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 41,900 43.00 662 77.48 n/a n/a n/a
2025-05-14 2025-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 29,300 6.16 373 -27.99 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Call 27,600 5,420.00 519 5,655.56 n/a n/a n/a
2025-02-14 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 27,600 519 n/a n/a n/a
2024-11-14 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 500 -85.29 10 -89.77 n/a n/a n/a
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 3,400 -89.51 88 -90.50 n/a n/a n/a
2024-05-10 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 32,400 -26.36 927 -31.20 n/a n/a n/a
2024-02-14 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 44,000 -16.03 1,346 -4.34 n/a n/a n/a
2023-11-09 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 52,400 -14.10 1,408 -35.31 n/a n/a n/a
2023-08-09 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 61,000 48.42 2,175 108.53 n/a n/a n/a
2023-05-12 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 41,100 -54.13 1,044 -71.30 n/a n/a n/a
2023-02-09 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 89,600 12.85 3,634 38.49 n/a n/a n/a
2022-11-09 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 79,400 25.83 2,624 18.09 n/a n/a n/a
2022-08-11 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 63,100 -41.36 2,222 -55.10 n/a n/a n/a
2022-05-12 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 107,600 -21.69 4,949 -45.68 n/a n/a n/a
2022-02-11 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 137,400 2.23 9,110 8.57 n/a n/a n/a
2021-11-12 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 134,400 7.35 8,391 -19.08 n/a n/a n/a
2021-08-10 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 125,200 36.68 10,369 70.71 n/a n/a n/a
2021-05-12 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 91,600 -68.58 6,074 -72.84 n/a n/a n/a
2021-02-10 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 291,500 264.83 22,367 550.20 n/a n/a n/a
2020-11-12 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 79,900 -52.53 3,440 -52.68 n/a n/a n/a
2020-08-13 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 168,300 35.29 7,269 103.10 n/a n/a n/a
2020-05-13 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 124,400 3.75 3,579 -52.94 n/a n/a n/a
2020-02-10 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 119,900 90.32 7,605 328.45 n/a n/a n/a
2019-11-12 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 63,000 -35.38 1,775 -31.31 n/a n/a n/a
2019-08-09 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 97,500 638.64 2,584 967.77 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Call 13,200 -74.66 242 -62.60 n/a n/a n/a
2019-05-13 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 13,200 242 n/a n/a n/a
2019-02-05 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 52,100 -73.49 647 -82.82 n/a n/a n/a
2018-11-08 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 196,500 6.68 3,767 50.38 n/a n/a n/a
2018-08-13 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 184,200 157.98 2,505 386.41 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Call 71,400 -66.88 515 -35.06 n/a n/a n/a
2018-05-10 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 71,400 515 n/a n/a n/a
2018-02-09 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 215,600 -5.60 793 -19.82 n/a n/a n/a
2017-11-15 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 228,400 989 n/a n/a n/a
2017-08-14 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-10 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 109,000 16.58 202 39.31 n/a n/a n/a
2017-02-15 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 93,500 -16.44 145 -82.36 n/a n/a n/a
2016-11-14 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 111,900 97.70 822 173.09 n/a n/a n/a
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 56,600 301 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 2,000 -82.46 133 -66.41 n/a n/a n/a
2025-11-12 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 11,400 -69.11 393 -32.59 n/a n/a n/a
2025-08-14 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 36,900 141.18 583 200.52 n/a n/a n/a
2025-05-14 2025-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 15,300 188.68 195 95.96 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Put 5,300 1,666.67 100 1,880.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 5,300 100 n/a n/a n/a
2024-11-14 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 300 -81.25 6 -87.80 n/a n/a n/a
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 1,600 -82.22 42 -84.05 n/a n/a n/a
2024-05-10 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 9,000 181.25 257 164.95 n/a n/a n/a
2024-02-14 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 3,200 -62.35 98 -57.46 n/a n/a n/a
2023-11-09 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 8,500 -61.36 228 -70.92 n/a n/a n/a
2023-08-09 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 22,000 566.67 785 844.58 n/a n/a n/a
2023-05-12 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 3,300 -91.79 84 -94.91 n/a n/a n/a
2023-02-09 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 40,200 -5.19 1,631 16.35 n/a n/a n/a
2022-11-09 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 42,400 -5.78 1,401 -11.55 n/a n/a n/a
2022-08-11 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 45,000 -33.33 1,584 -48.97 n/a n/a n/a
2022-05-12 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 67,500 -2.17 3,104 -32.15 n/a n/a n/a
2022-02-11 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 69,000 69.95 4,575 80.47 n/a n/a n/a
2021-11-12 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 40,600 3.57 2,535 -21.93 n/a n/a n/a
2021-08-10 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 39,200 84.04 3,247 129.96 n/a n/a n/a
2021-05-12 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 21,300 -52.88 1,412 -59.28 n/a n/a n/a
2021-02-10 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 45,200 64.96 3,468 193.90 n/a n/a n/a
2020-11-12 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 27,400 -41.70 1,180 -41.87 n/a n/a n/a
2020-08-13 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 47,000 -35.08 2,030 -2.54 n/a n/a n/a
2020-05-13 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 72,400 -23.63 2,083 -65.36 n/a n/a n/a
2020-02-10 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 94,800 293.36 6,013 785.57 n/a n/a n/a
2019-11-12 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 24,100 -72.01 679 -70.25 n/a n/a n/a
2019-08-09 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 86,100 2,107.69 2,282 3,069.44 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Put 3,900 -96.12 72 -94.23 n/a n/a n/a
2019-05-13 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 3,900 72 n/a n/a n/a
2019-02-05 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 100,400 191.86 1,247 89.23 n/a n/a n/a
2018-11-08 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 34,400 -34.35 659 -7.57 n/a n/a n/a
2018-08-13 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 52,400 -50.61 713 -6.80 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Put 106,100 -10.77 765 74.66 n/a n/a n/a
2018-05-10 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 106,100 765 n/a n/a n/a
2018-02-09 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 118,900 16.57 438 -0.90 n/a n/a n/a
2017-11-15 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 102,000 -0.29 442 166.27 n/a n/a n/a
2017-08-14 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 102,300 4.60 166 -8.29 n/a n/a n/a
2017-05-10 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 97,800 38.33 181 64.55 n/a n/a n/a
2017-02-15 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 70,700 -25.50 110 -84.24 n/a n/a n/a
2016-11-14 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 94,900 210.13 698 328.22 n/a n/a n/a
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 30,600 163 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.